Mark Harrison

3.2k total citations
68 papers, 1.5k citations indexed

About

Mark Harrison is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Harrison has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Surgery, 44 papers in Oncology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Harrison's work include Colorectal and Anal Carcinomas (37 papers), Colorectal Cancer Surgical Treatments (32 papers) and Colorectal Cancer Treatments and Studies (21 papers). Mark Harrison is often cited by papers focused on Colorectal and Anal Carcinomas (37 papers), Colorectal Cancer Surgical Treatments (32 papers) and Colorectal Cancer Treatments and Studies (21 papers). Mark Harrison collaborates with scholars based in United Kingdom, United States and Spain. Mark Harrison's co-authors include Rob Glynne‐Jones, Robert Hughes, J. Grainger, Andreas Makris, Richard Adams, David Sebag‐Montefiore, Timothy Iveson, Mark Saunders, M. Hawkins and J. L. Morse and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Mark Harrison

64 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Harrison United Kingdom 21 974 884 562 127 111 68 1.5k
Michitaka Nagase Japan 18 640 0.7× 666 0.8× 836 1.5× 178 1.4× 218 2.0× 51 1.3k
Sandy Beare United Kingdom 15 735 0.8× 786 0.9× 673 1.2× 103 0.8× 146 1.3× 30 1.4k
Hironaga Satake Japan 18 667 0.7× 372 0.4× 573 1.0× 52 0.4× 84 0.8× 147 1.1k
Yusuke Onozawa Japan 23 718 0.7× 656 0.7× 902 1.6× 59 0.5× 45 0.4× 129 1.7k
Gerardo Rosati Italy 20 1.4k 1.4× 893 1.0× 482 0.9× 27 0.2× 117 1.1× 112 1.7k
Javier Gállego Spain 21 875 0.9× 408 0.5× 485 0.9× 51 0.4× 134 1.2× 131 1.4k
J.-F. Bosset France 15 1.6k 1.7× 695 0.8× 699 1.2× 275 2.2× 226 2.0× 43 1.9k
Yoshito Yamashita Japan 21 409 0.4× 562 0.6× 529 0.9× 151 1.2× 173 1.6× 111 1.4k
Sarah Slater United Kingdom 14 527 0.5× 320 0.4× 650 1.2× 51 0.4× 84 0.8× 38 1.1k
Natsuko Okita Japan 20 855 0.9× 271 0.3× 518 0.9× 236 1.9× 91 0.8× 110 1.3k

Countries citing papers authored by Mark Harrison

Since Specialization
Citations

This map shows the geographic impact of Mark Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Harrison more than expected).

Fields of papers citing papers by Mark Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Harrison. The network helps show where Mark Harrison may publish in the future.

Co-authorship network of co-authors of Mark Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Harrison. A scholar is included among the top collaborators of Mark Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Harrison. Mark Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harrison, Mark, A. B. Muchnikov, А. Н. Макаров, et al.. (2025). Performance of neutron beam system for accelerator-based boron neutron capture therapy. 3(4). 94–94. 1 indexed citations
2.
Glynne‐Jones, Rob & Mark Harrison. (2024). Colorectal cancer para-aortic lymph node metastases: surgery should not be considered. British journal of surgery. 111(3). 2 indexed citations
3.
Aitken, K., J. Good, M. Hawkins, et al.. (2020). Liver Stereotactic Ablative Radiotherapy: an Effective and Feasible Alternative to Surgery during the COVID-19 Pandemic. Clinical Oncology. 32(7). 477–477. 4 indexed citations
4.
Khakoo, Shelize, Ian Chau, Ian Pedley, et al.. (2019). ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK. Clinical Colorectal Cancer. 18(4). 280–291.e5. 12 indexed citations
5.
Glynne‐Jones, Rob, Marcia Hall, Andre Lopes, et al.. (2018). BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC). Heliyon. 4(9). e00804–e00804. 20 indexed citations
7.
Glynne‐Jones, Rob, Marcia Hall, John Bridgewater, et al.. (2017). BACCHUS: A randomised study of neoadjuvant chemotherapy alone in patients with high-risk locally advanced rectal cancer. Annals of Oncology. 28. iii126–iii126. 1 indexed citations
8.
Glynne‐Jones, Rob, et al.. (2016). Background and Current Treatment of Squamous Cell Carcinoma of the Anus. Oncology and Therapy. 4(2). 135–172. 11 indexed citations
9.
Muirhead, R., K. Drinkwater, Séan M. O’Cathail, et al.. (2016). Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015. Clinical Oncology. 29(3). 188–197. 30 indexed citations
11.
Cutsem, Eric Van, C. Boni, Josep Tabernero, et al.. (2014). Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study. Annals of Oncology. 26(1). 149–156. 88 indexed citations
12.
Kelly, Claire, et al.. (2013). Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history. European Journal of Cancer. 49(10). 2303–2310. 75 indexed citations
13.
Glynne‐Jones, Rob, et al.. (2012). To PET or not to PET? That is the question. Staging in anal cancer. Annals of Oncology. 23(8). 2078–2082. 34 indexed citations
14.
Glynne‐Jones, Rob, David Sebag‐Montefiore, Richard Adams, et al.. (2012). Prognostic factors for recurrence and survival in anal cancer. Cancer. 119(4). 748–755. 59 indexed citations
15.
Aggarwal, Ajay, et al.. (2012). Clinical target volumes in anal cancer: Calculating what dose was likely to have been delivered in the UK ACT II trial protocol. Radiotherapy and Oncology. 103(3). 341–346. 10 indexed citations
16.
17.
Glynne‐Jones, Rob, et al.. (2011). Antiepidermal growth factor receptor radiosensitizers in rectal cancer. Anti-Cancer Drugs. 22(4). 330–340. 7 indexed citations
18.
Hughes, Robert, Mark Harrison, & Rob Glynne‐Jones. (2010). Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?. Acta Oncologica. 49(3). 378–381. 59 indexed citations
19.
Mawdsley, S., Rob Glynne‐Jones, J. Grainger, et al.. (2005). Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?. International Journal of Radiation Oncology*Biology*Physics. 63(3). 745–752. 81 indexed citations
20.
Harrison, Mark, David R. Tomlinson, & Suzanne Stewart. (1995). Squamous cell carcinoma of the anus in patients with AIDS. Clinical Oncology. 7(1). 50–51. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026